Andrea Corcoran serves as the Chief Financial Officer and Executive Vice President of Legal at ATEA Pharmaceuticals Inc., a biopharmaceutical company focused on developing novel antiviral therapeutics. With a robust background in both finance and law, Andrea brings a wealth of experience to her dual roles at ATEA. Prior to joining ATEA, she held significant positions in the pharmaceutical industry, including CFO at a mid-sized biotech firm where she successfully led the company through several rounds of funding and a high-profile merger. Her expertise in financial strategy and legal affairs has been instrumental in guiding ATEA through its growth phases and into clinical trials for its lead antiviral candidates. In her role at ATEA, Andrea is responsible for overseeing the company's financial operations, ensuring regulatory compliance, and managing legal matters. Her strategic approach to finance has helped ATEA secure vital investments and partnerships, positioning the company for future success in the competitive pharmaceutical market. Additionally, Andrea's legal acumen has been crucial in navigating the complex landscape of intellectual property and regulatory requirements in the biotech industry. Her leadership has not only strengthened ATEA's financial health but also enhanced its reputation for integrity and innovation in the development of life-saving therapies. Andrea's achievements extend beyond her corporate roles; she is an active member of several professional organizations dedicated to advancing the fields of finance and law within the pharmaceutical sector. She frequently speaks at industry conferences, sharing insights on the intersection of finance, legal strategy, and drug development. Under her guidance, ATEA Pharmaceuticals continues to make strides toward its mission of delivering groundbreaking antiviral treatments to patients worldwide.